ANNX News - Candlesense

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with de...

Governance

4 days ago

Annexon Selected by EMA to Participate in Product Development Coordinator Pilot for Vonaprument (ANX007) for Dry Age-Related Macular Degeneration with Geographic Atrophy

New Pilot Appoints Designated Product Development Coordinator to Navigate Regulatory Interactions, Respond to Ad-hoc Queries, and Support Evidence Planning

How does the sentiment score of 65 reflect market optimism, and should traders adjust their positions accordingly? Will the EMA's pilot potentially expedite market entry for Vonaprument, and how could that affect revenue forecasts? What risks remain for Annexon despite the EMA's support in navigating regulatory interactions and evidence planning?

Clinical

15 days ago